Mitoquidone
Mitoquidone (GR-30921) is is the first member of a group of pentacyclic pyrroloquinones. Mitoquidone shows good activity in a range of experimental solid tumour models. Mitoquidone can be used for the research of anti-cancer[1].
Product Specifications
CAS Number
91753-07-0
Product Name Alternative
GR-30921
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mitoquidone.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=CC=C12)C3=CN4CC5=C(C=CC=C5)CC4=C3C2=O
Molecular Formula
C20H13NO2
Molecular Weight
299.32
References & Citations
[1]P A Speth, et al. Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone. Cancer Chemother Pharmacol. 1988;21 (4) :343-6. |[2]Speth PA, et al. Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone. Cancer Chemother Pharmacol. 1988;21 (4) :343-6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ABC-X1054 1 Vial
Xpress™ Human FAM163A Over-expressing Stable Cell Line
Sign In for Pricing
View Details 